Founder Forum: Kevin Strange of Novo Biosciences

August 11, 2017

The goal now is to lead this drug candidate through clinical trials in large mammals and then, hopefully, demonstrate that it can help humans regenerate heart muscle tissue following a heart attack.

(Reprint from Maine Startups Insider 8/11/2017) – Kevin Strange is co-founder and CEO of Novo Biosciences, a four-year-old biotech startup in Bar Harbor that is working on nothing less than developing a drug that could provide humans with regenerative properties. Read more here.